nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—SSTR5—Peptide GPCRs—CCR9—Crohn's disease	0.0263	0.0267	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—CCR9—Crohn's disease	0.0243	0.0246	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—CCR9—Crohn's disease	0.0191	0.0194	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0188	0.0191	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—MLN—Crohn's disease	0.0178	0.0181	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.0176	0.0179	CbGpPWpGaD
Vapreotide—SSTR5—Peptide GPCRs—CCR6—Crohn's disease	0.0174	0.0177	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0174	0.0176	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—MLN—Crohn's disease	0.0165	0.0167	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—CCR6—Crohn's disease	0.0161	0.0163	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0147	0.015	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.0139	0.0141	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0137	0.0139	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0136	0.0138	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—MLN—Crohn's disease	0.0131	0.0133	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.013	0.0132	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—CCR6—Crohn's disease	0.0127	0.0129	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0126	0.0128	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.0124	0.0126	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.012	0.0122	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.0117	0.0119	CbGpPWpGaD
Vapreotide—Octreotide—MPO—Crohn's disease	0.0117	0.748	CrCbGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0116	0.0118	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.0114	0.0116	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.011	0.0112	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CCR9—Crohn's disease	0.0104	0.0106	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00968	0.00983	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CCR9—Crohn's disease	0.00963	0.00978	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—ACKR2—Crohn's disease	0.00961	0.00976	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00917	0.00932	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—MLN—Crohn's disease	0.00911	0.00926	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.009	0.00914	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00898	0.00913	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00893	0.00907	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—ACKR2—Crohn's disease	0.00887	0.00901	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00869	0.00883	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—GPR65—Crohn's disease	0.00846	0.00859	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—MLN—Crohn's disease	0.00841	0.00854	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.0083	0.00844	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00829	0.00842	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00819	0.00832	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00771	0.00783	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00765	0.00777	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00756	0.00768	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00756	0.00768	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00711	0.00723	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—ACKR2—Crohn's disease	0.00698	0.00709	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CCR6—Crohn's disease	0.00691	0.00702	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—MLN—Crohn's disease	0.00662	0.00672	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00641	0.00651	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CCR6—Crohn's disease	0.00638	0.00648	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCR9—Crohn's disease	0.00631	0.00642	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00603	0.00612	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00595	0.00604	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00592	0.00601	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—GPR65—Crohn's disease	0.00587	0.00596	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCR9—Crohn's disease	0.00583	0.00592	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00564	0.00573	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.0056	0.00569	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00549	0.00558	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—GPR65—Crohn's disease	0.00542	0.0055	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.00522	0.0053	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00521	0.00529	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—MLN—Crohn's disease	0.00515	0.00523	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00507	0.00515	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—ACKR2—Crohn's disease	0.00493	0.00501	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00484	0.00491	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—MLN—Crohn's disease	0.00475	0.00483	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MLN—Crohn's disease	0.00468	0.00475	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCR9—Crohn's disease	0.00459	0.00466	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—ACKR2—Crohn's disease	0.00455	0.00462	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00446	0.00453	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00437	0.00444	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MLN—Crohn's disease	0.00431	0.00438	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—GPR65—Crohn's disease	0.00427	0.00433	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCR6—Crohn's disease	0.00418	0.00425	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TLR4—Crohn's disease	0.00414	0.0042	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.00411	0.00417	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00399	0.00405	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—ICAM1—Crohn's disease	0.00397	0.00403	CbGpPWpGaD
Vapreotide—Desmopressin—PTGS2—Crohn's disease	0.00393	0.252	CrCbGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00391	0.00397	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCR6—Crohn's disease	0.00386	0.00392	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—MLN—Crohn's disease	0.00374	0.0038	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—PTGER4—Crohn's disease	0.00368	0.00374	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ACKR2—Crohn's disease	0.00358	0.00364	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR9—Crohn's disease	0.00357	0.00363	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00351	0.00357	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—PTGER4—Crohn's disease	0.0034	0.00345	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MLN—Crohn's disease	0.0034	0.00345	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—GPR65—Crohn's disease	0.00332	0.00337	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR9—Crohn's disease	0.00329	0.00335	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR9—Crohn's disease	0.00324	0.00329	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—GPR65—Crohn's disease	0.00306	0.00311	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCR6—Crohn's disease	0.00304	0.00309	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IFNG—Crohn's disease	0.00302	0.00307	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—GPR65—Crohn's disease	0.00301	0.00306	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR9—Crohn's disease	0.00299	0.00304	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ACKR2—Crohn's disease	0.00291	0.00296	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—PTGS2—Crohn's disease	0.00289	0.00294	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.00285	0.0029	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CXCL8—Crohn's disease	0.00281	0.00285	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—GPR65—Crohn's disease	0.00278	0.00282	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MLN—Crohn's disease	0.00276	0.00281	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.00274	0.00278	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL1B—Crohn's disease	0.00269	0.00274	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ACKR2—Crohn's disease	0.00269	0.00273	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—PTGER4—Crohn's disease	0.00268	0.00272	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00264	0.00268	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR9—Crohn's disease	0.00259	0.00263	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MLN—Crohn's disease	0.00255	0.00259	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TAGAP—Crohn's disease	0.00253	0.00257	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00244	0.00247	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GPR65—Crohn's disease	0.00241	0.00245	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR6—Crohn's disease	0.00236	0.0024	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR9—Crohn's disease	0.00235	0.00239	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TAGAP—Crohn's disease	0.00233	0.00237	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.00225	0.00228	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00223	0.00226	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RSPO3—Crohn's disease	0.00221	0.00224	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GPR65—Crohn's disease	0.00219	0.00222	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR6—Crohn's disease	0.00218	0.00222	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.00215	0.00219	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR6—Crohn's disease	0.00215	0.00218	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ACKR2—Crohn's disease	0.00212	0.00215	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SEL1L—Crohn's disease	0.00209	0.00213	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PTGER4—Crohn's disease	0.00208	0.00211	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00205	0.00209	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RSPO3—Crohn's disease	0.00204	0.00207	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MLN—Crohn's disease	0.00201	0.00204	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00199	0.00203	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.00198	0.00202	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR6—Crohn's disease	0.00198	0.00201	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TNF—Crohn's disease	0.00195	0.00198	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SEL1L—Crohn's disease	0.00193	0.00196	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PTGER4—Crohn's disease	0.00192	0.00195	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00192	0.00195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR9—Crohn's disease	0.00191	0.00194	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.0019	0.00193	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PTGER4—Crohn's disease	0.00189	0.00192	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TAGAP—Crohn's disease	0.00184	0.00186	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GPR65—Crohn's disease	0.00178	0.00181	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL3—Crohn's disease	0.00177	0.0018	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00177	0.0018	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR9—Crohn's disease	0.00177	0.00179	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PTGER4—Crohn's disease	0.00174	0.00177	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR6—Crohn's disease	0.00172	0.00174	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00171	0.00174	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GPR65—Crohn's disease	0.00164	0.00167	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL3—Crohn's disease	0.00164	0.00166	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00163	0.00166	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL3—Crohn's disease	0.00161	0.00164	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RSPO3—Crohn's disease	0.0016	0.00163	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.0016	0.00163	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00158	0.00161	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL6—Crohn's disease	0.00158	0.0016	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.00156	0.00159	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR6—Crohn's disease	0.00156	0.00158	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—RASGRP1—Crohn's disease	0.00156	0.00158	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SEL1L—Crohn's disease	0.00152	0.00154	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00151	0.00154	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL3—Crohn's disease	0.00149	0.00151	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—RASGRP1—Crohn's disease	0.00144	0.00146	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR9—Crohn's disease	0.00139	0.00141	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PTGER4—Crohn's disease	0.00137	0.0014	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL8—Crohn's disease	0.00135	0.00137	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GPR65—Crohn's disease	0.00129	0.00131	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL3—Crohn's disease	0.00129	0.00131	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00129	0.00131	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR6—Crohn's disease	0.00127	0.00129	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.00126	0.00128	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00125	0.00127	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL8—Crohn's disease	0.00124	0.00126	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2RA—Crohn's disease	0.00124	0.00126	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR6—Crohn's disease	0.00117	0.00119	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL3—Crohn's disease	0.00117	0.00119	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RBX1—Crohn's disease	0.00115	0.00117	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2RA—Crohn's disease	0.00115	0.00116	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00113	0.00115	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2RA—Crohn's disease	0.00113	0.00115	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTGER4—Crohn's disease	0.00112	0.00113	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RBX1—Crohn's disease	0.00106	0.00108	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2RA—Crohn's disease	0.00104	0.00106	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTGER4—Crohn's disease	0.00103	0.00105	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—UBE2D1—Crohn's disease	0.00101	0.00102	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL8—Crohn's disease	0.000979	0.000995	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000976	0.000991	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RIPK2—Crohn's disease	0.000975	0.000991	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL3—Crohn's disease	0.000951	0.000966	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—UBE2D1—Crohn's disease	0.000928	0.000943	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR6—Crohn's disease	0.000921	0.000936	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RASGRP1—Crohn's disease	0.00092	0.000934	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000902	0.000917	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RIPK2—Crohn's disease	0.0009	0.000914	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL3—Crohn's disease	0.000878	0.000892	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RASGRP1—Crohn's disease	0.000849	0.000862	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—JAK2—Crohn's disease	0.000835	0.000848	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SOCS1—Crohn's disease	0.000833	0.000847	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RBX1—Crohn's disease	0.000833	0.000847	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2RA—Crohn's disease	0.000819	0.000832	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTGER4—Crohn's disease	0.000811	0.000824	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TYK2—Crohn's disease	0.000795	0.000807	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—JAK2—Crohn's disease	0.00077	0.000783	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SOCS1—Crohn's disease	0.000769	0.000781	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL8—Crohn's disease	0.000762	0.000774	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—JAK2—Crohn's disease	0.000758	0.00077	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TYK2—Crohn's disease	0.000733	0.000745	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—UBE2D1—Crohn's disease	0.000731	0.000742	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SMAD3—Crohn's disease	0.000719	0.000731	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RIPK2—Crohn's disease	0.000709	0.00072	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000703	0.000714	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—JAK2—Crohn's disease	0.000699	0.000711	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL8—Crohn's disease	0.000692	0.000703	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL3—Crohn's disease	0.000691	0.000702	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RASGRP1—Crohn's disease	0.000668	0.000679	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2RA—Crohn's disease	0.000666	0.000677	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SMAD3—Crohn's disease	0.000664	0.000674	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL8—Crohn's disease	0.000638	0.000649	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2RA—Crohn's disease	0.000615	0.000625	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—JAK2—Crohn's disease	0.000606	0.000616	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SOCS1—Crohn's disease	0.000605	0.000615	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TYK2—Crohn's disease	0.000577	0.000586	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000553	0.000562	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—JAK2—Crohn's disease	0.000551	0.000559	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SMAD3—Crohn's disease	0.000523	0.000531	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL8—Crohn's disease	0.000503	0.000511	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2RA—Crohn's disease	0.000484	0.000492	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TYK2—Crohn's disease	0.000469	0.000477	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JAK2—Crohn's disease	0.000448	0.000455	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TYK2—Crohn's disease	0.000433	0.00044	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JAK2—Crohn's disease	0.000413	0.00042	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL8—Crohn's disease	0.000409	0.000415	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—Crohn's disease	0.000389	0.000395	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL8—Crohn's disease	0.000377	0.000383	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—Crohn's disease	0.000359	0.000364	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TYK2—Crohn's disease	0.000341	0.000346	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STAT3—Crohn's disease	0.000329	0.000334	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JAK2—Crohn's disease	0.000325	0.00033	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STAT3—Crohn's disease	0.000303	0.000308	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL8—Crohn's disease	0.000297	0.000302	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—Crohn's disease	0.000282	0.000287	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STAT3—Crohn's disease	0.000239	0.000243	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—Crohn's disease	0.00023	0.000233	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—Crohn's disease	0.000212	0.000215	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—Crohn's disease	0.000167	0.000169	CbGpPWpGaD
